Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Alkaloid AD Skopje's Enterprise Value is MKD36,645 Mil.
Alkaloid AD Skopje's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was MKD2,273 Mil. Therefore, Alkaloid AD Skopje's EV-to-EBIT ratio for today is 16.12.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Alkaloid AD Skopje's Enterprise Value is MKD36,645 Mil.
Alkaloid AD Skopje's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was MKD2,273 Mil. Therefore, Alkaloid AD Skopje's EV-to-EBITDA ratio for today is 16.12.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Alkaloid AD Skopje's Enterprise Value is MKD36,645 Mil.
Alkaloid AD Skopje's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was MKD20,945 Mil. Therefore, Alkaloid AD Skopje's EV-to-Revenue ratio for today is 1.75.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Alkaloid AD Skopje (XMAE:ALK) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Alkaloid AD Skopje's current Enterprise Value is MKD36,645 Mil.
Alkaloid AD Skopje's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MKD2,273 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Alkaloid AD Skopje's current Enterprise Value is MKD36,645 Mil.
Alkaloid AD Skopje's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MKD2,273 Mil.
Alkaloid AD Skopje's current Enterprise Value is MKD36,645 Mil.
Alkaloid AD Skopje's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MKD20,945 Mil.
Alkaloid AD Skopje's current Enterprise Value is MKD36,645 Mil.
Alkaloid AD Skopje's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MKD0 Mil.
Alkaloid AD Skopje's current Enterprise Value is MKD36,645 Mil.
Alkaloid AD Skopje's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MKD0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alkaloid AD Skopje Enterprise Value Related Terms
Alkaloid AD Skopje Enterprise Value Historical Data
* Premium members only.
The historical data trend for Alkaloid AD Skopje's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XMAE:ALK vs ZTS, UTHR, VTRS: Enterprise Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Alkaloid AD Skopje's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alkaloid AD Skopje Enterprise Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Alkaloid AD Skopje's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Alkaloid AD Skopje's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Alkaloid AD Skopje's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of MKD36,645 Mil mean?
Alkaloid AD Skopje (XMAE:ALK) has a Enterprise Value of MKD36,645 Mil as of Jun. 30, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Alkaloid AD Skopje and its competitors.
Is Alkaloid AD Skopje's Enterprise Value too high?
Alkaloid AD Skopje's current Enterprise Value is MKD36,645 Mil. Overall, Alkaloid AD Skopje has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alkaloid AD Skopje's Enterprise Value compare to ZTS and UTHR?
Alkaloid AD Skopje's Enterprise Value of MKD36,645 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Alkaloid AD Skopje and its competitors. Alkaloid AD Skopje's current Enterprise Value is MKD36,645 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alkaloid AD Skopje stock overvalued right now?
Based on GuruFocus' analysis, Alkaloid AD Skopje (XMAE:ALK) is currently considered Modestly Undervalued. The stock's GF Value™ is MKD27,166.15, compared to a current price of MKD24,150.00 — trading 11.1% below its estimated fair value. The current Enterprise Value is MKD36,645 Mil. Alkaloid AD Skopje's overall GF Score™ is 88/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Alkaloid AD Skopje (XMAE:ALK), the current Enterprise Value is MKD36,645 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alkaloid AD Skopje (XMAE:ALK) Overvalued in 2026?
Based on GuruFocus' analysis, Alkaloid AD Skopje stock appears to be undervalued.
The current stock price of MKD24,150.00 is trading 11.1% below its estimated GF Value™ of MKD27,166.15.
GuruFocus considers Alkaloid AD Skopje to be Modestly Undervalued.
Key valuation signals for XMAE:ALK:
Enterprise Value: MKD36,645 Mil
GF Value™: MKD27,166.15 vs. price of MKD24,150.00 (11.1% below fair value)
No single metric tells the full story. See the XMAE:ALK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alkaloid AD Skopje is engaged in producing and selling pharmaceutical, chemical and cosmetic products, as well as goods from the herbal origin. Its segments are Pharmaceuticals, Chemicals, Cosmetics and Botanicals. It derives maximum revenue from Pharmaceuticals products segment.
88GF Score
Get the complete analysis for XMAE:ALK
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAE:ALK has been successfully added to your 
